Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Prevention/Epidemiology

Reuters Examines HIV/AIDS Prevention Strategies Targeting IDUs

April 26, 2010

"Countries in eastern Europe and central Asia face spiralling AIDS epidemics if they fail to help people who inject drugs and stop the spread of infection, [Michel Sidibe,] the head of the United Nations agency for HIV/AIDS said on Friday," Reuters reports in a piece that examines Sidibe's comments on several HIV/AIDS prevention strategies aimed at injecting drug users (IDUs). "Infection prevention steps like providing needles, condoms and substitute drugs like methadone -- collectively known as harm reduction -- are seen by many experts as key to halting the spread of HIV and AIDS, but some governments are reluctant to provide them for fear of being seen to condone drug use," the news service writes. According to Reuters, Sidibe was scheduled Sunday to address a conference on harm reduction in Liverpool (Kelland, 4/23). In a second story, Reuters examines the amount of funding that goes towards harm reduction, as described in report (.pdf) released Monday by the International Harm Reduction Association (Kelland, 4/26).

Back to other news for April 2010


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.


  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
Ask Our Expert, David Fawcett, Ph.D., L.C.S.W., About Substance Use and HIV
More on Harm Reduction With Intravenous Drugs

 

Advertisement